Specific features of diagnosis and treatment in pregnant women with uncomplicated urinary tract infection and urogenital infections


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Urinary disorders in women with recurrent urinary tract infections (UTI) are a serious problem that has not yet been solved despite that there are a large number of papers on this topic. Pregnant women who have experienced acute urinary tract infection and those who have been treated for asymptomatic bacteriuria should be followed up until delivery, by examining their urine to prove the efficiency of antibacterial therapy that can threaten their pregnancy. It is necessary to emphasize the importance of prevention, timely detection of signs of UTI in pregnant women and the correct choice of antibiotic therapy in the developed UTI.

Full Text

Restricted Access

About the authors

Zaida K. Gadzhieva

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: zgadzhieva@ooorou.ru
MD, urologist at the UKB №2, Deputy Director of RSU for work with regions, RSU board member, scientific editor of Journal «Urologiia».

Mikhail A. Gomberg

Moscow Research and Practical Center for Dermatovenereology and Cosmetology

Email: centr@mosderm.ru
M.D., professor, chief researcher

Vagarskak A. Grigoryan

I.M. Sechenov First Moscow State Medical University (Sechenov University)

MD, professor, Institute for Urology and Human Reproductive Health

Magomed A. Gazimiev

I.M. Sechenov First Moscow State Medical University (Sechenov University)

MD, Deputy Director of the Institute for Urology and Human Reproductive Health, Deputy Director and Executive Director of the Russian Society of Urology (RSU), RSU board member, Deputy Editor-in-Chief of Newspaper “Vestnik ROU”.

Yusup B. Kazilov

N.M. Kuraev Republican Children's Clinical Hospital

MD, pediatric urologist and andrologist Makhachkala, Russia

References

  1. Аляев Ю.Г., Глыбочко П.В., Пушкарь Д.Ю., ред. Урология. Российские клинические рекомендации. М.; 2018: 501-18.
  2. Логутова Л.С., ред. Тактика ведения беременных с хронической болезнью почек и бактериурией. Пособие для врачей. М.; 2012.
  3. Клинические рекомендации Европейской ассоциации урологов, 2017. М.; 2017. 1224с.
  4. Глыбочко П.В., Аляев Ю.Г., ред. Интегративная урология. Руководство для врачей. М.: Медфорум; 2014. 432с.
  5. Kazemier B.M., Koningstein F.N., Schneeberger C., Ott A., Bossuyt P.M., de Miranda E. et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect. Dis. 2015; 15(11): 1324 33. http://dx.doi.org/10.1016/S1473-3099(15)00070-5
  6. Widmer M., Lopez I., Gülmezoglu A.M., Mignini L., Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst. Rev. 2015; (11): CD000491. https://www.ncbi.nlm.nih.gov/ pubmed/26560337
  7. Синякова Л.А., Косова И.В. Инфекции мочевых путей у беременных. Современные подходы к лечению. Эффективная фармакотерапия. 2008; 12: 6-13.
  8. Kresken M., Körber-Irrgang B., Biedenbach D.J., Batista N., Besard V., Canton R. et al. Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries. Clin. Microbiol. Infect. 2016; 22(1): 63. e1-63. e5.
  9. Мавров Г.И., Пиньковская Л.И. Лечение гонореи и неспецифических инфекций мочевыводящих путей цефиксимом (обзор литературы и собственные исследования). Украинский журнал дерматологии, венерологии, косметологии. 2014; 4: 66-72.
  10. Гаджиева З.К., Казилов Ю.Б. Особенности подхода к диагностике и лечению рецидивирующих инфекций нижних мочевыводящих путей. Урология. 2013; 3 (Приложение 3): 15-34.
  11. Козырев Ю.В. Бессимптомная бактериурия у беременных: лечебно-диагностические аспекты: автореф. дис.. канд. мед. наук. М.; 2013.
  12. Ahmadi A., Khodabandehloo M., Ramazanzadeh R., Farhadifar F., Nikkhoo B., Soofizade N., Rezaii M. Association between Ureaplasma urealyticum endocervical infection and spontaneous abortion. Iran. J. Microbiol. 2014; 6(6): 392-7.
  13. Taylor-Robinson D. Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium. Res. Microbiol. 2017; 168(9-10): 875-81.
  14. Cox C., Watt A.P., McKenna J.P., Coyle P.V. Mycoplasma hominis and Gardnerella vaginalis display a significant synergistic relationship in bacterial vaginosis. Eur. J. Clin. Microbiol. Infect. Dis. 2016; 35(3): 481-7.
  15. Haahr T., Jensen J.S., Thomsen L., Duus L., Rygaard K., Humaidan P. Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients. Hum. Reprod. 2016; 31(4): 795-803.
  16. Leli C., Meucci M., Vento S., D’Alo F., Farinelli S., Perito S. et al. Microbial and vaginal determinants influencing Mycoplasma hominis and Ureaplasma urealyticum genital colonization in a population of female patients. Infez. Med. 2013; 21(3): 201-6.
  17. Allen-Daniels M.J., Serrano M.G., Pflugner L.P., Fettweis J.M., Prestosa M.A., Koparde V.N. et al. Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intraamniotic infection. Am. J. Obstet. Gynecol. 2015; 212(6): 779. e1-779. e13.
  18. Taylor-Robinson D., Jensen J.S., Svenstrup H., Stacey C.M. Difficulties experienced in defining the microbial cause of pelvic inflammatory disease. Int. J. STD AIDS. 2012; 23: 18-24.
  19. De Francesco M.A., Caracciolo S., Bonfanti C., Manca N. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years. J. Infect. Chemother. 2013; 19(4): 621-7.
  20. Ye G., Jiang Z., Wang M., Huang J., Jin G., Lu S. The resistance analysis of Ureaplasma urealyticum and Mycoplasma hominis in female reproductive tract specimens. Cell Biochem. Biophys. 2014; 68(1): 207-10.
  21. Zhou Y.H., Ma H.X., Yang Y., Gu W.M. Prevalence and antimicrobial resistance of Ureaplasma spp. and Mycoplasma hominis isolated from semen samples of infertile men in Shanghai, China from 2011 to 2016. Eur. J. Clin. Microbiol. Infect. Dis. 2018; 37(4): 729-34. doi: 10.1007/ s10096-017-3167-5.
  22. Maraki S., Mavromanolaki V., Nioti E., Stafylaki D., Minadakis G. Prevalence and antimicrobial susceptibility of Ureaplasma species and Mycoplasma hominis in Greek female outpatients, 2012-2016. J. Chemother. 2018; 30(3): 140-4. doi:1 0.1080/1120009X.2017.1404287.
  23. Jensen J.S., Cusini M., Gomberg M., Moi H. European guideline on Mycoplasma genitalium infections. J. Eur. Acad. Dermatol. Venereol. 2016; 30(10): 1650-6. doi: 10.1111/jdv.13849.
  24. Manhart L.E., Gillespie C.W., Lowens M.S., Khosropour C.M., Colombara D.V., Golden M.R. et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin. Infect. Dis. 2013; 56(7): 934-42.
  25. Horner P., Blee K., Adams E. Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! Curr. Opin. Infect. Dis. 2014; 27(1): 68-74.
  26. Gesink D.C., Mulvad G., Montgomery-Andersen R., Poppel U., Monrgomery-Andersen S., Binzer A. et al. Mycoplasma genitalium presence, resistance and epidemiology in Greenland. Int. J. Circumpolar. Health. 2012; 71: 1-8.
  27. Guschin A., Ryzhikh P., Rumyantseva T., Gomberg M., Unemo M. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin. BMC Infect. Dis. 2015; 15: 40.
  28. Приказ Минздрава России от 13.10.2017 N 804н «Об утверждении номенклатуры медицинских услуг» (Зарегистрировано в Минюсте России 07.11.2017 N 48808).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies